SRS Capital Advisors »

Acelrx Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $91 81 1.14

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Acelrx Pharmaceuticals

AIGH Capital Management
Rock Springs Capital Management
Rosalind Advisors
Nantahala Capital Management
Empery Asset Management
Bleichroeder
Caption Management
Vanguard Group
Cantor Fitzgerald, L. P.
Geode Capital Management
Susquehanna International
Jane Street
Renaissance Technologies
Dauntless Investment Group
BlackRock

View all funds holding Acelrx Pharmaceuticals